BACKGROUND: The objective of this study was to determine the prevalence of Chlamydia trachomatis among both men and women seeking help at an infertility clinic, and to prospectively follow the effect of previous infection on pregnancy rates and pregnancy outcome after a long follow-up period (mean 37 months). METHODS: A total of 244 infertile couples was tested for C. trachomatis IgG antibodies, and IgG + couples were also tested for C. trachomatis DNA by PCR in a ®rst-void urine sample. Study parameters were serology, PCR results, clinical diagnoses, treatments, pregnancy rates and pregnancy outcome. As controls, age-matched and spontaneously pregnant women were also tested with serology. RESULTS: The prevalence of IgG antibodies was 24.2, 20.1 and 15.6% among infertile women, infertile men and control women respectively. The prevalence of C. trachomatis DNA was 6.8 and 7.1% among tested women and men respectively. The presence of C. trachomatis IgG antibodies in women was related to tubal factor infertility (TFI) (P = 0.002). Decreased pregnancy rates were seen in couples where the man was IgG + (P = 0.005) with no relationship to TFI. Among women who achieved pregnancy, there was no difference in pregnancy outcome between IgG + or negative couples. CONCLUSIONS: C. trachomatis IgG antibodies in the man of the infertile couple was related to decreased pregnancy rates and to the presence of IgG antibodies in the woman. There was a high prevalence of asymptomatic persistent infections among infertile couples.
Introduction
Chlamydia trachomatis is one of the most prevalent sexually transmitted diseases (STD) worldwide. In Sweden the incidence rate has increased from 157 to 189 per 100 000 from 1997 to 1999 (Gotz et al., 2002) , and even further during recent years (Ekdahl, 2002 ). An infection with C. trachomatis is known to be dif®cult to diagnose and can persist in the genital tract for a long period of time (Witkin, 2002) . Persistence of genital chlamydia infections has recently been demonstrated in 87% of untreated men and women (Joyner et al., 2002) . The ®nding of C. trachomatis IgG antibodies, as a marker of previous or persistent infection, shows a high prevalence in women with tubal factor infertility (TFI) (Mol et al., 1997) . TFI is suggested to reduce pregnancy rates after IVF (Strandell et al., 2000) and the clinical demonstration of a Fallopian tube persistently dilated by¯uid (hydrosalpinx) is in itself a negative predictor for pregnancy (Strandell et al., 1994) , but details of the suggested mechanism(s) are as yet unknown. A recent meta-analysis concluded that laparoscopic salpingectomy prior to IVF treatment increases the odds of pregnancy and live birth as compared with no salpingectomy in the short term (Johnson et al., 2002) .
When it comes to the relevance of testing for C. trachomatis in infertility investigation of the male partner, opinions diverge. Whether C. trachomatis exerts a direct effect on sperm quality or whether the male accessory glands are merely reservoirs for C. trachomatis bacteria that are repeatedly transmitted to the female partner, thereby causing for example tubal damage and diminished pregnancy chances, or a combination of both, remains unknown. There is, to our knowledge, only one previous study that has investigated the relationship between male partner C. trachomatis IgG antibodies and subsequent pregnancy rates. That study reported a lower pregnancy rate after a 6 month follow-up period, among couples where the man was positive for C. trachomatis IgG (Eggert-Kruse et al., 1990) .
The present study was undertaken to determine the prevalence of C. trachomatis antibodies and ongoing infections in couples attending the gynaecological outpatient clinic because of infertility. An additional aim was to correlate the presence of C. trachomatis antibodies in the male and female partner to pregnancy rates and pregnancy outcome, whether achieved spontaneously or after assisted reproduction techniques. For controls, age-matched women attending the maternity screening programme and reporting spontaneous pregnancies were tested for the prevalence of IgG-antibodies to C. trachomatis.
Materials and methods
This study was a prospective cohort study and the Human Ethics Committee of the Medical Faculty, Umea Ê University, approved of all parts.
Patients and specimen sampling During the period October 1997 through February 2001 all consecutive couples (n = 244) attending the gynaecological outpatient clinic at Umea Ê University Hospital due to infertility (unful®lled desire for pregnancy for >1 year) were included in the study. Blood was drawn from both partners upon their ®rst visit, and tested for the occurrence of IgG antibodies to C. trachomatis after informed consent. Both partners were tested for HIV and hepatitis B and C. The female was tested for rubella immunity, and for ovulation by using mid-luteal serum progesterone. Semen analysis (using criteria according to the World Health Organization as modi®ed by NAFA/ ESHRE; Kvist and Bjo Èrndahl, 2002) of the man was undertaken. The couple received general information about the investigation to come. If one of the partners of the couple had C. trachomatis IgG antibodies (threshold level 1/20), a second blood test for con®rmation of the result was drawn and a ®rst-void urine sample for detection of C. trachomatis DNA was collected. If at least one of the partners was positive in the DNA test for C. trachomatis, they were both treated with doxycycline 100 mg Q2 the ®rst day and thereafter doxycycline 100 mg Q1 for 9 more days. None of the partners who had a positive DNA test admitted to extramarital sexual activity.
Chlamydia trachomatis serology and DNA testing C. trachomatis-speci®c IgG antibodies were determined by the microimmuno¯uorescence (MIF) test (MRL Diagnostics/Focus, USA). Serum dilutions starting at 1/40 up to 1/640 were used. A weak speci®c immuno¯uorescence in the 1/40 dilution was reported as positive in 1/20. Antibody incubations were performed at 37°C for 60 min. Positive and negative controls from the kit were included. Upon receipt, the urine specimens were analysed for C. trachomatis DNA by means of a commercially available PCR test (Cobas Amplicor C. trachomatis test; Roche Diagnostics, Switzerland) according to the instructions from the manufacturer. For each specimen an internal control was included. A negative test result was reported as negative only if the sample was negative for C. trachomatis and the internal control was positive. A sample positive for C. trachomatis was re-analysed and reported as positive if the re-analysis was also positive.
Clinical investigation
Within 1±3 months after their ®rst visit, when all test results were available, the couple returned to the clinic for a further consultation. This visit was conducted according to routine infertility work-up including clinical examination and ultrasonography, and further investigations such as hysterosalpingosonography (HSS) (n = 87), laparoscopy (n = 66), or both (n = 20) and additional hormonal assays were planned. From here on the couples were advised about treatment according to the ®ndings. TFI was de®ned as one or both tubes occluded or dilated at HSS or laparoscopic chromopertubation.
Follow-up
After a follow-up period of 14±54 months (mean 37 months), the medical records of all couples included were studied with respect to C. trachomatis IgG antibodies and C. trachomatis DNA, ®ndings at HSS and laparoscopy, clinical diagnoses, treatments and reported pregnancies. Primary endpoints of the study were pregnancy and pregnancy outcome (passed 28 weeks of gestation, spontaneous abortion or ectopic pregnancy). All pregnancies were routinely screened by ultrasound at gestation week 15±17. Those couples who had not achieved pregnancy by the time the medical records were studied were contacted by mail with information about the study and a request to contact them by telephone. During a structured telephone interview (carried out by A.I.) they were asked about any treatments not found in the medical records (some couples were treated elsewhere) and pregnancies and pregnancy outcome that had not previously been recorded. Six couples (2.5%) were lost to follow-up, of whom three couples had emigrated and the remaining three did not respond or were unreachable. Thus, pregnancy data were available from 238/244 (97.5%) of the couples.
Fertile controls
Retrospectively, serum was analysed from women attending the Antenatal Care programme at the local health care centres caring for women in the same region as the women attending the gynaecological outpatient clinic. At their ®rst visit, blood had been collected for analysis of rubella immunity and an additional aliquot of serum was banked. Using the database from the computerized medical records, samples from these women were matched to the women seeking help for infertility with respect to age (birth year) and the year when blood samples were collected. Only women with spontaneous pregnancies (as recorded in the medical records) were included (n = 244). Serum was analysed with respect to the presence of IgG antibodies to C. trachomatis by the same method as for the study population. 
Statistics
The statistical analyses were performed using SPSS software version 10.0.7. For signi®cance of difference between two independent groups, the c 2 -test, and, in applicable cases, Fisher's exact test, were used. P < 0.05 was considered signi®cant. Spearman's non-parametric rank correlation was used for calculating correlations. Odds ratios (OR) and con®dence intervals (95% CI) were calculated by multiple logistic regression and multivariate analysis was performed. To minimize the chance of getting a Type 1 error when making multiple comparisons, a Bonferroni±Holm adjustment of P-values was done.
Results

Patients
Mean age of the women was 31.1 T 4.7 (mean T SD) years and of the men 34.0 T 5.4 years. Duration of infertility was b1 year but in isolated cases ranging up to 10 years. For the female partner the infertility was primary in 138/244 (56.6%) of the women and secondary in 106/244 (43.4%). In those women where the infertility was secondary, the woman had either had a child or had a history of spontaneous abortion, extrauterine pregnancy or induced abortion.
Clinical diagnoses, Chlamydia trachomatis IgG and DNA prevalence
For distribution of the principal diagnoses, see Table I . Nineteen per cent of the women had TFI as one of three diagnoses. In the subgroup that underwent IVF/ICSI treatment, the proportion that had TFI as one of three diagnoses was 22/57 (39%). For details of C. trachomatis IgG prevalence and DNA positivity, see Table II . None of the patients complained of symptoms indicating ongoing STD. In the control group of pregnant women the prevalence of C. trachomatis IgG antibodies was 38/244 (15.6%), which was signi®cantly different from the prevalence in the group of infertile women (OR 1.73, 95% CI 1.10±2.72, P = 0.023). The ®nding of a positive C. trachomatis DNA ampli®cation test using PCR was equally distributed in both sexes and in only one couple were both partners positive (Table II) . All nine couples where either one or both partner(s) were positive in the C. trachomatis PCR test were treated with antibiotics. One month after treatment, all couples were PCR-tested again with a negative test result. Four out of these nine couples had TFI as the principal cause of infertility. During the follow-up period, three of nine treated couples achieved pregnancies, all spontaneously.
Chlamydia trachomatis IgG and DNA among women and relationship to TFI and pregnancy rates The ®nding of C. trachomatis IgG in the women was signi®cantly related to the ®nding of TFI (Table III) . The presence of C. trachomatis IgG antibodies in the woman among all couples tested (independent of diagnosis) was not related to pregnancy (Table III) . In the small group of IVFtreated couples, the relationship between the woman's C. trachomatis IgG and pregnancy did not reach statistical a Both partners of a couple where the woman, the man or both were positive in IgG-testing were tested with PCR on ®rst-void urine specimen. b Refers to number of couples where at least one of the partners was positive. signi®cance (n = 32, OR 4.2, 95% CI 0.9±19.4, P = 0.13). In the C. trachomatis IgG ± group, 15/20 were able to establish a pregnancy as compared with only 5/12 in the C. trachomatis IgG + group. There was a signi®cant, albeit weak, correlation between the level of the women's C. trachomatis IgG titres and the ®nding of a positive PCR test (r = 0.3, P = 0.026).
Chlamydia trachomatis IgG and DNA among men and relationship to pregnancy rates
The ®nding of C. trachomatis IgG in the male partners was a highly signi®cant outcome predictor with an OR of 2.6 (95% CI 1.3±4.9, P = 0.005) (Table III) of not achieving pregnancy.
In the subgroup of couples that did not go through IVF or ICSI treatment, the OR of not achieving pregnancy if the man was C. trachomatis IgG + was even higher (OR 3.9, 95% CI 1.4± 10.9, P = 0.012). However, there was no signi®cant relationship between C. trachomatis IgG antibodies in the man and male factor infertility, the latter as judged by sperm analysis. There was no relationship between C. trachomatis IgG antibodies in the man and TFI in the female partner. No other signi®cant relationships between male IgG positivity and possible confounding variables were seen (i.e. endometriosis, partner's age, treatments etc.). In the IVF or icsi group the C. trachomatis IgG ± men achieved pregnancy in 28/43 (65.1%) of the cases as compared with 6/14 (42.9%) among C. trachomatis IgG + men. There was a highly signi®cant relationship between C. trachomatis IgG-positivity in the man and the woman (Table III) and also a signi®cant correlation between their respective IgG titre levels (r = 0.4, P < 0.001).
Pregnancy outcome
For women who achieved pregnancy during the study period, whether spontaneous or treatment-related, there were no statistically signi®cant differences between C. trachomatis IgG + or negative men and/or women concerning pregnancy outcome (Table IV) . Furthermore, there were no differences in pregnancy outcome following different assisted reproduction treatments provided to C. trachomatis IgG + or negative couples (data not shown). Although the diagnosis of a male factor seemingly was related to a higher incidence of spontaneous abortions (P = 0.025), this was found to be not signi®cant when Bonferroni±Holm correction was applied.
Multivariate analysis
In a multivariate analysis, only one parameter was found to signi®cantly in¯uence the primary study outcome. The ®nding of C. trachomatis IgG antibodies in the male partner was related to a decreased likelihood of achieving pregnancy (Table III) .
Discussion
As anticipated, we found a raised prevalence of C. trachomatis IgG antibodies in the infertile population as compared with a proven fertile population. The presence of C. trachomatis IgG antibodies in the male partner of the infertile couple was signi®cantly and inversely correlated to the overall pregnancy rate, with an OR of 2.6 of not achieving pregnancy. An interesting ®nding in this study is that while a decreased pregnancy rate was seen in IgG + couples, there were no differences in pregnancy outcome between IgG + and IgG ± couples. There was also a high prevalence of PCR-detected C. trachomatis infections among couples exhibiting C. trachomatis IgG antibodies (13.1% of IgG + couples or 3.7% of the entire study group). Arguably, it should be cost-bene®cial to screen infertile C. trachomatis IgG + patients using PCR to detect and treat a possible persistent infection, since this has been suggested to be cost-effective in populations with a prevalence of C. trachomatis of b4% (Paavonen et al., 1998) . The strength of this study was the relatively long follow-up period (mean 37 months) with few patients lost to follow-up (2.5%). However, the cohort was too small to make any ®rm conclusions as to the possible impact of circulating antibodies to C. trachomatis in some of the study subgroups. DNA testing was only performed if one of the partners exhibited C. trachomatis IgG antibodies. Hence it is not possible to comprehensively evaluate the predictive value of a positive C. trachomatis IgG test and the chance of detecting an ongoing C. trachomatis infection. Nevertheless, the C. trachomatis IgG titre levels were signi®cantly correlated to DNA ®ndings, suggesting that there were very fewÐif anyÐDNA + cases among those that were C. trachomatis IgG ± . Punnonen et al. (1979) clearly demonstrated an association between C. trachomatis seropositivity and TFI (Mol et al., 1997) . Similar to that ®nding, in the present study we found an OR of 3.6 of demonstrating tubal occlusion in a subsequent HSS or laparoscopy following a positive C. trachomatis IgG test of the female partner. There are diverging results from published studies, whether or not C. trachomatis IgG antibodies are a negative predictor for IVF outcome. Several studies have demonstrated a negative relationship (Rowland et al., 1985; Lunenfeld et al., 1989; Sharara and Queenan, 1999) , while a few (smaller) studies did not ®nd such a relationship (Torode et al., 1987; Tasdemir et al., 1994) . In one study, doxycycline treatment may have masked the negative effect of C. trachomatis antibodies (Sharara et al., 1997) . Such antibiotic treatment may cure a hidden residual infection since a correlation between C. trachomatis antibodies and ®ndings of antigen in ovarian, tubal and endometrial samples (Czerwenka et al., 1994) has been demonstrated. However, C. trachomatis antigen has been identi®ed in Fallopian tubes, ovaries and endometrium of culture-negative women with tubal factor infertility (Toth et al., 2000) and ectopic pregnancies (Barlow et al., 2001) . Nonetheless, mechanisms other than residual C. trachomatis infections may reduce the pregnancy rate in spontaneous or assisted reproductive cycles. Repeated or persistent C. trachomatis infections are suggested to elicit an autoimmune response to human heat shock proteins (HSP) due to the structural similarities to chlamydial HSP (Neuer et al., 1997; Witkin et al., 1998) . This may in turn exert a negative in¯uence on embryo development and implantation at vital stages when human HSP are expressed, resulting in decreased reproductive outcome (Witkin, 1999; Neuer et al., 2000) . The present study draws attention to the interesting ®nding that male chlamydia IgG positivity confers a decreased fecundity in affected couples. Although as yet speculative, since they were not included as parameters in the present study, decreased sperm motility or concurrent or undetected infection may play a role. It is known that infection with Mycoplasma genitalium, which is also sexually transmitted, is an established cause of acute and probably also persistent non-gonococcal urethritis (NGU) (Taylor-Robinson, 2002) . Use of serological tests in women attending an infertility clinic has suggested that M. genitalium may be an independent risk factor in the development of tubal damage (Clausen et al., 2001 ). The present study was not aimed to evaluate a possible effect of C. trachomatis IgG on semen characteristics of the male partner. However, no signi®cant relationship between C. trachomatis IgG seropositivity and the diagnosis on conventional spermiogram parameters indicative of male factor infertility, was found. In one study comprising 491 asymptomatic males of infertile couples (Eggert-Kruse et al., 1990) a negative in¯uence of male C. trachomatis IgG antibodies on pregnancy rates after 6 months was reported. The authors concluded that the effect was probably due to sexual transmission and a negative in¯uence on tubal function of the female partner, since male C. trachomatis IgG positivity was correlated to female TFI. There was no such correlation between C. trachomatis IgG antibodies in the male and TFI in the present study, suggesting that there might be alternative or additional mechanism(s) that can reduce fertility. Several studies have addressed the relationship between C. trachomatis IgG and IgA antibodies in serum and semen and sperm quality but few signi®cant relationships have been shown (Bjercke and Purvis, 1992; Dieterle et al., 1995; Eggert-Kruse et al., 1996; Weidner et al., 1996; Habermann and Krause, 1999; Ochsendorf et al., 1999) . However, Gdoura et al. (2001) found an association between C. trachomatis DNA in semen and reduced sperm motility. In this context it is interesting to note that a recent study has demonstrated that co-incubation of sperm for 1±6 h with C. trachomatis serovar E increased the proportion of immotile and dead sperm (Hosseinzadeh et al., 2001 ).
In conclusion, we suggest that C. trachomatis antibody testing of both the male and female partner of the couple should be included in the routine infertility work-up in order to enable a more adequate prognosis for the likelihood of a spontaneous pregnancy. It remains to be seen in a randomized controlled study if antibiotic treatment to C. trachomatis IgG positive infertile patients and/or to all, as suggested by Land et al. (2002) , will increase the couple's likelihood to achieve pregnancy in spontaneous and/or assisted reproductive cycles.
